Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology
Sato, Y
It is not suitable for treating optic neuropathies associated with elevated plasma concentrations of cyanocobalamin
It is offered solely as an in-vitro research reference material
Because AOD-9604 does not bind to growth hormone receptors in liver, muscle, or adipose tissue, it cannot trigger the metabolic pathways that mediate growth hormones counter-regulatory effects on glucose metabolism
NAD+ / MOTS-C / 5-Amino-1MQ, research compound, third party tested, COA available, Disguised Alpha, Freeze Dried Isolates NAD+ / MOTS-C / 5-Amino-1MQ is commonly positioned around NNMT pathway research, NAD metabolism models, metabolic signaling studies
US$ 20.96
US$ 27.04
US$ 25.25
US$ 25.19
US$ 22.82
